Try our Advanced Search for more refined results
Life Sciences - May, 2007
122 articles
- Townsend Steps Up Its Biotech Team
- California Drops Claims Against Bristol-Myers
- DenTek Answers Medtech's Infringement Claims
- Consumer Group Backs Purchasers In Fraud Case
- Court Tosses Verdict, $3M Award Against Wyeth
- Cordis Gets New Stent Patent, Sues Abbott
- Judge Gives Go-Ahead To Prilosec Patent Suit
- Amended Complaint Filed Over Ditropan
- Becton Dickinson Seeks More Time In Antitrust Suit
- Bristol-Myers Pleads Guilty, Pays $1M In Fines
- Roche Loses First Accutane Trial, Jury Awards $2.5M
- Purdue, Impax Patent Fight Comes To An End
- Takeda Files New Suit Against Teva Over Prevacid
- Pfizer To Appeal Lipitor Patents In Norway
- Uncle Sam Wants You...To Examine Patent Claims
- FDA Takes Aim At Unapproved Cough Drugs
- Whistleblower Suit Against Schering To Proceed
- House Threatens FDA With Subpoena
- ITC Once Again Delays Phone Chip Penalty Decision
- Judge Sets Evidentiary Hearing In Seroquel Case
- Judge Throws Out Slew Of Cases Against Pfizer
- Two Suits Added To OxyContin Antitrust Case
- Ivax Pushes For Depomed To Share Memos
- Life Sciences Industry Says FDA Needs Reform
- Supreme Court Shouldn't Hear Tamoxifen Cases: SG
- ITC To Ban Qualcomm Phone Chips: Experts
- Altana, Sun Squabble Over Discovery Motions
- Ortho Evra Cases Consolidated In Ohio
- Fresenius Renews Bid To Stay Damages Trial
- Supreme Court Reins In U.S. Patent Law
- Biotech Bankruptcies Face IP Challenges
- Norvasc Patent Still Invalid: Court
- FDA Issues Warning Over Avandia Amid Outcry
- Counterclaims Filed In HIV Treatment Patent Suit
- Court Lifts Order Barring Teva's Generic Lotrel
- Open Source's New Weapon: KSR v. Teleflex Ruling
- Immucor Settles for $2.5 Million
- AstraZeneca Sued Over Seroquel Promotions
- Takeda Sues Over Diabetes Drug Patent
- MediaTek Dealt Setback In Chip Dispute
- Zydus Takes Aim At Three Rivers' Hep C Patent
- Boston Scientific Tries To Settle Guidant Claims
- Leapfrog V. Fisher-Price: Lessons Learned
- SeraCare Emerges, Settles Securities Suit
- Patent Reform Bill Clears First Hurdle
- Cases Added to Suit Over Wyeth, Pfizer HRT
- IP Blacklist Lacks Teeth: Experts
- Judge Grants Bid To Toss BioSafe's Ch. 11 Case
- Abbott Wants New J&J Stent Patent Declared Invalid
- Judge Dismisses Bavarian's Trade Secrets Case
- Biotech Co. Fires Back Against Applera
- Merck Files Second Suit Against Teva Over Singulair
- Kinetic, Wake Forest File VAC Patent Complaints
- Sanofi-Aventis Sues To Protect Ambien Market
- AstraZeneca Sued Over Breast Cancer Drug
- Abbott Sues To Protect Depakote ER
- FDA Improvement Act Introduced In House
- KSR Opens Numerous U.S. Patents To Reexamination
- Roche Workers Lose Appeal Of ERISA Claims
- Microsoft Seeks New Trial In Patent Case
- Par's ANDA Leads To Infringement Suit
- Schering Faces Class Action Over Alleged Kickbacks
- SEC Sends Biovail Wells Notice
- Bad Day At Black Rock II
- Supreme Court Won't Touch EPO Patent Spat
- Allergan, Inamed Smooth Out Concerns Over Reloxin
- Edwards Unit Sues Rival Over Catheter Device
- J&J Keeps Cheap Risperdal Off Shelves
- Genendo Loses Drug Importation Appeal
- Wyeth's Sales Tactics Not Anti-Competitive: Court
- Court Keeps Aciphex Free Of Generic Competition
- Plavix Charges Settled, But More May Be Coming
- AIG Unit Sues Tyco Over Bond Buyback Offer
- Appeals Court Calls LeapFrog's Toy Patent "Obvious"
- Group Says "Enough" In Pfizer Unit Ch. 11 Case
- U.S. Regulators Crack Down On Medicare Fraud
- Drug Bill To Change ANDA Petition Process
- Boston Scientific Faces German Patent Suit
- Digene Loses Belated Bid For Ban On Rival HPV Tests
- Purdue, Employees To Pay $700M In OxyContin Case
- Allergan Litigates Over Eye Drop Patent
- Biovail Chair Fails To Reach Deal With Regulator
- Clinton Unveils Pact To Slash AIDS Drug Prices
- China's Ex-FDA Head To Go On Trial For Corruption
- Cardinal Health Settles Suit For $600M
- District Court Denies Abbott's Motion To Dismiss
- Exxon Seeks Injunction Against Web Domain Buyer
- Senate Drug Importation Amendment Squashed
- Philippines Seeks To Invalidate Pfizer Patent
- Medicis Settles Off-Label Marketing Charges
- Chevron Nears Iraqi Kickback Settlement: Report
- Purdue Pharma Settles With States Over OxyContin
- Top Companies Join In Push For Health Care Reform
- Lundbeck Loses U.K. Patent Case Over Cipralex
- Study: Bill Could Drive Up Drug Costs by Billions
- U.K. Plaintiffs Dismissed From Hemophilia Case
- Hospital Operator Seeks Transfer Of Antitrust Suit
- Thailand Makes IP Blacklist For Compulsory Licenses
- Lawmakers, Unions Fight FDA Plan To Close Labs
- Judge Excludes Accutane Maker's Own Assessments
- PTO Issues Memo On KSR Decision To Examiners
- Brazil Breaks Patent On Merck's AIDS Drug
- KSR v. Teleflex, Redefining The Obvious
- BioSafe Brokers $6M Deal With Creditors
- German Court OKs Bayer-Schering Merger
- Reed Smith Nabs Experienced FDA Partner
- FDA Gives Mylan Tentative OK On Generic Femara
- AstraZeneca Warns Against "Procedural Chaos"
- Teleflex Ruling Doesn't Win Vonage New Trial
- Merck Alleges Infringement Of Antibacterial Drug
- Health Plan Contraception Exclusion Not Discriminatory
- Biologics Debated At House Subcommittee Hearing
- EBG Launches Clinical Trial Help Group
- Infertility Claim Against Eli Lilly Dismissed
- Canadian Court Blocks Generic Celebrex Launch
- Pennsylvania To Review Insurance Merger
- Bush Opposes Adding Biologic Generics To FDA Bill
- FDA Attempt To Quash Subpoenas Denied
- New Hampshire Data Law Ruled Unconstitutional
- KSR V. Teleflex Creates Uncertainty
- Judge Recommends Revoking Impax's Registration
- Bingham McCutchen Joins Forces With Litigation Firm